# PEG-IFN Plus Ribavirin Combination Therapy for Older Patients

> **NCT00956982** · NA · UNKNOWN · sponsor: **Kyushu University** · enrollment: 1251 (estimated)

## Conditions studied

- Hepatitis C Virus

## Interventions

- **DRUG:** Pegylated interferon alpha-2b plus ribavirin

## Key facts

- **NCT ID:** NCT00956982
- **Lead sponsor:** Kyushu University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-12
- **Primary completion:** 2008-07
- **Final completion:** 2012-12
- **Target enrollment:** 1251 (ESTIMATED)
- **Last updated:** 2009-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956982, "PEG-IFN Plus Ribavirin Combination Therapy for Older Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00956982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*